Suppr超能文献

多发性硬化症患者外周血和脑脊液中的体内活化T淋巴细胞。

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

作者信息

Hafler D A, Fox D A, Manning M E, Schlossman S F, Reinherz E L, Weiner H L

出版信息

N Engl J Med. 1985 May 30;312(22):1405-11. doi: 10.1056/NEJM198505303122201.

Abstract

We found an increase in peripheral-blood lymphocytes bearing the T-cell-specific activation antigen Ta1 in 20 of 35 patients with progressive multiple sclerosis, 4 of 18 patients with stable or improving multiple sclerosis, 1 of 17 patients with other neurologic diseases, and 1 of 14 normal controls (P less than 0.0002, Fisher's exact test). No increases in two other markers of T-cell activation, T113 and the interleukin-2 receptor, were found. In the cerebrospinal fluid, patients with progressive multiple sclerosis (pleocytosis, 3.9 +/- 1.6 cells per cubic millimeter) had 42 +/- 3.0 per cent Ta1+ cells. In contrast, patients with other inflammatory central nervous system diseases (36 +/- 13 cells per cubic millimeter) had 9.6 +/- 1.8 per cent Ta1+ cells (P less than 0.01). In patients with other neurologic diseases without inflammation (0.7 +/- 0.16 cells per cubic millimeter), the percentage of Ta1+ cells was equivalent to that in patients with multiple sclerosis (39 +/- 5.4 per cent), although the absolute number was lower. There was a positive correlation between the presence of Ta1+ cells in the spinal fluid and blood of patients with other neurologic diseases, but not patients with multiple sclerosis. Less than 1 per cent of lymphocytes from the spinal fluid of patients with multiple sclerosis expressed interleukin-2 receptors, as compared with 9.8 per cent of cells from subjects with other inflammatory neurologic diseases (P less than 0.01). These results suggest that the T cells in the spinal fluid of patients with multiple sclerosis may be activated by a different mechanism or in a different temporal sequence from that in patients with other nervous system diseases. Furthermore, the increase in Ta1+ cells in the peripheral blood of patients with multiple sclerosis demonstrates systemic immune activation in the disease; monitoring such cells may provide an objective measure of abnormal immunologic activity.

摘要

我们发现,在35例进行性多发性硬化患者中有20例、18例病情稳定或改善的多发性硬化患者中有4例、17例其他神经系统疾病患者中有1例以及14例正常对照者中有1例,其外周血中带有T细胞特异性活化抗原Ta1的淋巴细胞数量增加(P<0.0002,Fisher精确检验)。未发现另外两种T细胞活化标志物T113和白细胞介素-2受体数量增加。在脑脊液中,进行性多发性硬化患者(细胞增多症,每立方毫米3.9±1.6个细胞)的Ta1+细胞占42±3.0%。相比之下,其他炎症性中枢神经系统疾病患者(每立方毫米36±13个细胞)的Ta1+细胞占9.6±1.8%(P<0.01)。对于无炎症的其他神经系统疾病患者(每立方毫米0.7±0.16个细胞),Ta1+细胞的百分比与多发性硬化患者相当(39±5.4%),尽管绝对数量较低。其他神经系统疾病患者脑脊液和血液中Ta1+细胞的存在呈正相关,但多发性硬化患者并非如此。多发性硬化患者脑脊液中的淋巴细胞不到1%表达白细胞介素-2受体,而其他炎症性神经系统疾病患者的细胞中有9.8%表达(P<0.01)。这些结果表明,多发性硬化患者脑脊液中的T细胞可能通过与其他神经系统疾病患者不同的机制或不同的时间顺序被激活。此外,多发性硬化患者外周血中Ta1+细胞的增加表明该疾病存在全身性免疫激活;监测此类细胞可能为异常免疫活动提供客观指标。

相似文献

引用本文的文献

2
Basic principles of neuroimmunology.神经免疫学基本原理。
Semin Immunopathol. 2022 Sep;44(5):685-695. doi: 10.1007/s00281-022-00951-7. Epub 2022 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验